Homebiotech

biotech

biotech

Revvity to acquire Human Cell Design

Jim Cornall - September 16, 2026

biotech

Engineered immune cells trial to fight colorectal cancer approved

Jim Cornall - September 16, 2026

biotech

Elix and Axcelead DDP to collaborate on targeted protein degrader discovery

Jim Cornall - September 16, 2026

biotech

Lotus Neuro launches to deliver therapies across blood-brain barrier

Jim Cornall - September 15, 2026

biotech

First FDA-approved treatment for MacTel

Jim Cornall - August 14, 2025

biotech

Lilly weight loss drug averages 27.3 lbs lost

Jim Cornall - August 14, 2025

biotech

XtalPi and DoveTree launch $6bn AI drug discovery collaboration

Jim Cornall - August 13, 2025

biotech

Anbio Biotechnology develops Chikungunya rapid test

Jim Cornall - August 13, 2025

biotech

AMI Pharm advances fat-reduction injectable drug to phase 3

Jim Cornall - August 13, 2025

biotech

AI+CRISPR=Precise gene editing

Jim Cornall - August 12, 2025

biotech

AXA signs agreement with Hainan Boao Lecheng Administration

Jim Cornall - August 12, 2025

biotech

ProBio launches AAV manufacturing service

Jim Cornall - August 12, 2025

1...828384...100 Page 83 of 100

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

Revvity to acquire Human Cell Design

Jim Cornall - September 16, 2026 0

Revvity, Inc. has entered into a definitive agreement to acquire Human Cell Design (HCD), a France-based biotechnology company specialising in human cell models and...

Engineered immune cells trial to fight colorectal cancer approved

biotech Jim Cornall - September 16, 2026 0

Elix and Axcelead DDP to collaborate on targeted protein degrader discovery

biotech Jim Cornall - September 16, 2026 0

Lotus Neuro launches to deliver therapies across blood-brain barrier

biotech Jim Cornall - September 15, 2026 0

Antibody targeting TSLP achieves positive results in asthma study

biotech Jim Cornall - September 15, 2026 0